Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Detagen Genetic Diseases Diagnosis and Evaluation Center is a specialized medical diagnostic facility based in Kayseri, Turkey, providing comprehensive genetic testing services. The center offers a broad range of molecular and cytogenetic analyses, including Next-Generation Sequencing (NGS), Whole Exome Sequencing (WES), and non-invasive prenatal testing (NIPT). Licensed by the Turkish Ministry of Health, Detagen focuses on identifying genetic mutations associated with rare diseases, oncology, and reproductive health. The facility operates within the Erciyes Teknopark ecosystem, utilizing advanced biotechnological platforms to deliver precise clinical data for personalized medicine. It serves as a key diagnostic partner for hospitals and clinicians, facilitating the diagnosis of complex hereditary conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Detagen Genetic Diseases Diagnosis and Evaluation Center.